Evidence map›Paper›PMID 34859010›Full record

ArticleFrontiers in medicine2021

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma.

Fang Wen, Shuai Ruan, Wenjie Huang, Xiaoxue Chen, Yulan Wang, Suping Gu, Jiatong Liu, Shenlin Liu, Peng Shu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fang WenDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Shuai RuanDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Wenjie HuangDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Xiaoxue ChenDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Yulan WangDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Suping GuDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Jiatong LiuDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Shenlin LiuDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Peng ShuDepartment of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Jiangsu Province Hospital · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical squamous cell carcinoma is one of the most common causes of female cancer deaths worldwide. At present, immunotherapy using immune checkpoint blockade (ICB) has improved the prognosis of many cancer patients, and neoantigens generated by mutations may serve as potential biomarkers for predicting the outcome of ICB therapy. In this study, we identified missense mutations as the most frequent in landscapes of gene mutation in cervical squamous cell carcinoma (CESC) samples. Patients with higher tumor mutation burden (TMB) presented higher overall survival (OS). In addition, there was a significant correlation between the high TMB group and fractions of most immune cells. Univariate and multivariate Cox regression analyses identified five hub genes (IFNG, SERPINA3, CCL4L2, TNFSF15, and IL1R1) that were used to build a prognostic model. In the prognostic model, the low-risk group achieved better OS. Mutations in the five hub genes mainly affected the infiltration level of CD8+ T cells and dendritic cells. In conclusion, our study is valuable for exploring the role of TMB and its relationship with immune infiltration in CESC. Moreover, the prognosis model may help predict the sensitivity of patients to immunotherapy and provide underlying biomarkers for personalized immunotherapy.

Indexed as

cervical squamous cell carcinomaimmune infiltrationprognosisTCGAtumor mutation burden

Identifiers

PMID34859010
PMCPMC8631969
OpenAlexW3213008577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.